Moneycontrol PRO
HomeNewsCoronavirus vaccine

Coronavirus Vaccine

Jump to
  • Stopped manufacturing, supply of Covishield vaccine since December 2021: Serum Institute

    The Indian drugmaker said it is committed to transparency and safety and had taken all the required steps to disclose the rare side effects of the vaccine

  • Have fever, running nose and cough? Know the difference between Adenovirus, H3N2 and Covid

    Have fever, running nose and cough? Know the difference between Adenovirus, H3N2 and Covid

    A cocktail of viruses is spreading through India, and it is difficult to differentiate between the overlapping symptoms of these infections. Here's what you need to know about adenovirus, H3N2 and Covid-19 strains

  • Only 27-28% beneficiaries have taken precaution dose of COVID-19 vaccine

    Only 27-28% beneficiaries have taken precaution dose of COVID-19 vaccine

    The Union health minister on December 21 reviewed the COVID-19 situation in the country and asked people to follow COVID-appropriate behaviour, including wearing masks in crowded places, and getting vaccinated.

  • Pfizer rides Paxlovid sales to better-than-expected quarter

    Pfizer rides Paxlovid sales to better-than-expected quarter

    The pill treatment Paxlovid brought in $7.5 billion in sales in the quarter and has generated more than $17 billion so far this year.

  • Health Ministry to stop procuring fresh COVID-19 vaccines, surrenders Rs 4,237 crore from vaccination budget

    Health Ministry to stop procuring fresh COVID-19 vaccines, surrenders Rs 4,237 crore from vaccination budget

    According to the Ministry of Health and Family Welfare, 219.32 crore doses of the coronavirus vaccine have been administered to beneficiaries across the country so far.

  • COVID-19 vaccine | Over 206 crore doses administered in India so far

    COVID-19 vaccine | Over 206 crore doses administered in India so far

    Those aged 60 years and above have so far been administered 3.44 crore precaution doses of the coronavirus vaccine.

  • UK to offer fourth COVID-19 vaccine shot to all aged 50 years and above

    UK to offer fourth COVID-19 vaccine shot to all aged 50 years and above

    Like many European countries, Britain is experiencing a surge in COVID-19 cases, driven by the ultra-contagious BA.4 and BA.5 subvariants of the omicron strain.

  • US rolls out COVID-19 vaccines for children under five

    US rolls out COVID-19 vaccines for children under five

    The United States has delivered about 2.7 million doses of COVID vaccines for children below five years to administration centres while another one million shots will reach the sites soon, the Department of Health and Human Services said on June 22.

  • COVID-19 Vaccine | Corbevax gets DCGI nod as heterologous booster dose

    COVID-19 Vaccine | Corbevax gets DCGI nod as heterologous booster dose

    COVID-19 Vaccine: With this, Corbevax becomes the first vaccine approved as a heterologous Covid-19 booster.

  • Covaxin approved for restricted emergency use in children aged 6-12 years

    Covaxin approved for restricted emergency use in children aged 6-12 years

    The regulator has asked Bharat Biotech to submit safety data, including the data on adverse event with due analysis, every 15 days for the first two months and monthly thereafter up to five months

  • Moderna says trial results suggest redesigned vaccines can better protect against variants

    Moderna says trial results suggest redesigned vaccines can better protect against variants

    The company’s findings, published in a paper without being evaluated by outside scientists, offer hope that the nation will have a better vaccine by the fall, when the coronavirus is considered likely to reemerge in force.

  • India reports 2,568 new COVID-19 cases, 97 deaths in 24 hours

    India reports 2,568 new COVID-19 cases, 97 deaths in 24 hours

    In two states and UTs, there is no active COVID-19 case now while in 4 others, there are less than 20 active infections.

  • COVID-19 vaccine for 12-14-year-olds to start from March 16; all above 60 years can take boosters

    COVID-19 vaccine for 12-14-year-olds to start from March 16; all above 60 years can take boosters

    The new decision will mean that, while Corbevax will be offered to the younger adolescents, those in the 15-17-year age group will continue to get Covaxin.

  • Adar Poonawalla, CEO of vaccine maker Serum Institute, has a message for Novak Djokovic

    Adar Poonawalla, CEO of vaccine maker Serum Institute, has a message for Novak Djokovic

    Unvaccinated tennis player Novak Djokovic has said that though he is not against COVID-19 vaccines, he will skip tournaments if compelled to take the jab.

  • Eco-Leftists and the Far Right: Vaccine Mandate Forges Unlikely Coalition of Protesters in Germany

    Eco-Leftists and the Far Right: Vaccine Mandate Forges Unlikely Coalition of Protesters in Germany

    Germany, with a vaccination rate of 69%, has the largest share of unvaccinated people among big Western European nations, and its organized resistance to vaccines may be more pronounced than anywhere else in Europe.

  • CoWIN Update: Six members can now register using one mobile number

    CoWIN Update: Six members can now register using one mobile number

    "Instead of the existing limit of 4 members, now 6 members can be registered using one mobile number on Co-WIN", read the government's order.

  • Over 40 lakh children get COVID-19 vaccine on first day; Parents say it is a big relief

    Over 40 lakh children get COVID-19 vaccine on first day; Parents say it is a big relief

    ''Congrats to all my young friends between the age group of 15-18 who got vaccinated. Congrats to their parents as well. I would urge more youngsters to get vaccinated in the coming days!", PM Modi tweeted.

  • School ID cards of children will be accepted for vaccination: CoWIN's RS Sharma

    School ID cards of children will be accepted for vaccination: CoWIN's RS Sharma

    RS Sharma is the CEO of the National Authority and chairperson of the empowered committee for CoWin.

  • Coronavirus Update | Active COVID-19 cases in country decline to 86,415

    Coronavirus Update | Active COVID-19 cases in country decline to 86,415

    Coronavirus Update | The death toll climbed to 4,76,869 with 391 fresh fatalities, according to the data updated at 8 am.

  • Covishield effectiveness in fully vaccinated 63% during 2nd wave: Study

    Covishield effectiveness in fully vaccinated 63% during 2nd wave: Study

    The study was published in ‘The Lancet Infectious Diseases’ journal and it included a comparison between 2,379 cases of confirmed SARS-CoV-2 infection and 1,981 controls. The vaccine’s effectiveness against SARS-CoV-2 infection in fully vaccinated individuals was found to be 63 percent.

  • As travel begins to rebound, are employees of Indian airlines vaccinated?

    As travel begins to rebound, are employees of Indian airlines vaccinated?

    The risk of infection spreading on airplanes is lower if Covid-19 protocols, including vaccination, are adhered to. Researchers say the danger of transmission is highest during meal services as well as boarding and departure procedures

  • 100 crore Covid vaccines administered: Survey finds 61% Indian citizens willing to take third dose

    100 crore Covid vaccines administered: Survey finds 61% Indian citizens willing to take third dose

    About 27 percent of respondents in a LocalCircles Survey said they would want a third dose only if COVID-19 is or likely to become prevalent at the time of availability of the third dose.

  • CoWin chief RS Sharma on India clocking 1 billion vaccinations

    CoWin chief RS Sharma on India clocking 1 billion vaccinations

    India has created history by vaccinating 100 crore (1 billion) people in less than a year. RS Sharma, CEO of the National Health Authority, said India’s COVID-19 vaccine delivery tech platform CoWin has been designed to absorb even higher numbers and can make swift changes in line with the government’s vaccination policy. Sharma, who is chairperson of the empowered committee for CoWin, spoke about the factors that helped India clock this milestone, its significance and the various ways in which CoWin can be re-purposed by the government going forward. Sharma was also the former chief of the Unique Identification Authority of India (UIDAI), the semi-government body tasked with rolling out the national identity project Aadhaar.

  • India's vaccine century: India Inc says 100 crore doses is a big confidence builder

    India's vaccine century: India Inc says 100 crore doses is a big confidence builder

    India needs to continue to double down on the pace as it presses ahead to fully vaccinate the entire adult population, India's top business leaders and entrepreneurs have said.

  • Municipal Corporation of Amdavad offers edible oil, lucky draw for taking COVID -19 vaccine

    Municipal Corporation of Amdavad offers edible oil, lucky draw for taking COVID -19 vaccine

    The initiative is an effort to create awareness of the vaccine and its benefits against COVID-19.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347